J van Dongen - JoVE Visualize

Showing results (301-310 of 328) with videos related to

Pageof 33

Sort By:

Journal of Pharmaceutical and Biomedical Analysis|September 13, 2022

Quantification of uracil, dihydrouracil, thymine and dihydrothymine for reliable dihydropyrimidine dehydrogenase (DPD) phenotyping critically depend on blood and plasma storage conditionsSebastian A H van den Wildenberg, Alexander S Streng, Renske van den Broek, et al.

Leukemia|March 23, 1999

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALLP Lúcio, A Parreira, M W van den Beemd, et al.

Clinical Pharmacology and Therapeutics|October 21, 2021

Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast CancerLaura Molenaar-Kuijsten, C Louwrens Braal, Stefanie L Groenland, et al.

Human Mutation|January 11, 2000

Genetic variation in ICF syndrome: evidence for genetic heterogeneityC Wijmenga, R S Hansen, G Gimelli, et al.

Leukemia|October 12, 1999

Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemiaS Bevan, D Catovsky, A Marossy, et al.

Leukemia|August 2, 2001

BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical EvaluationP Lucio, G Gaipa, E G van Lochem, et al.

Breast (Edinburgh, Scotland)|July 2, 2023

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trialV C M Geurts, L Voorwerk, S Balduzzi, et al.

Leukemia|December 22, 1999

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemiaJ J van Dongen, E A Macintyre, J A Gabert, et al.

American Journal of Human Genetics|August 27, 1998

Localization of the ICF syndrome to chromosome 20 by homozygosity mappingC Wijmenga, L P van den Heuvel, E Strengman, et al.

Leukemia|May 10, 2000

BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)A Porwit-MacDonald, E Björklund, P Lucio, et al.

Pageof 33

Showing results (301-310 of 328) with videos related to

Sort By:

Pageof 33

Journal of Pharmaceutical and Biomedical Analysis|September 13, 2022

Quantification of uracil, dihydrouracil, thymine and dihydrothymine for reliable dihydropyrimidine dehydrogenase (DPD) phenotyping critically depend on blood and plasma storage conditionsSebastian A H van den Wildenberg, Alexander S Streng, Renske van den Broek, et al.

Leukemia|March 23, 1999

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALLP Lúcio, A Parreira, M W van den Beemd, et al.

Clinical Pharmacology and Therapeutics|October 21, 2021

Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast CancerLaura Molenaar-Kuijsten, C Louwrens Braal, Stefanie L Groenland, et al.

Human Mutation|January 11, 2000

Genetic variation in ICF syndrome: evidence for genetic heterogeneityC Wijmenga, R S Hansen, G Gimelli, et al.

Leukemia|October 12, 1999

Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemiaS Bevan, D Catovsky, A Marossy, et al.

Leukemia|August 2, 2001

BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical EvaluationP Lucio, G Gaipa, E G van Lochem, et al.

Breast (Edinburgh, Scotland)|July 2, 2023

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trialV C M Geurts, L Voorwerk, S Balduzzi, et al.

Leukemia|December 22, 1999

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemiaJ J van Dongen, E A Macintyre, J A Gabert, et al.

American Journal of Human Genetics|August 27, 1998

Localization of the ICF syndrome to chromosome 20 by homozygosity mappingC Wijmenga, L P van den Heuvel, E Strengman, et al.

Leukemia|May 10, 2000

BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)A Porwit-MacDonald, E Björklund, P Lucio, et al.

Pageof 33